Cargando…

Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain

Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe disease temporarily related to SARS-CoV-2. We aimed to describe the epidemiological, clinical, and laboratory findings of all MIS-C cases diagnosed in children < 18 years old in Catalonia (Spain) to study their trend throu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pino, Rosa, Antoñanzas, Jesús M., Paredes-Carmona, Fernando, Perramon, Aida, Rivière, Jacques G., Coma, Maria, Martínez-Mejías, Abel, Ripoll, Francesc, López, Núria, Conti, Romina, Sala-Castellví, Pere, Ruiz, Montserrat, Brio, Sonia, García-Lorenzo, Marc, Esteller, Maria, Carreras-Abad, Clara, Herrero-Hernando, Carlos, Schneider, Stephan Otto, Gatell, Anna, Aguilar, Isabel, Cantero, Javier, Ruiz, Gloria, Fenollosa, Teresa, Lobato, Zulema, Villalobos, Pilar, Mora, Emiliano, Anton, Jordi, Visa-Reñé, Núria, Soler-Palacin, Pere, Calavia, Olga, Esquirol-Herrero, Cristina, Guarch-Ibañez, Borja, García-García, Juan-José, Coma, Ermengol, Fina, Francesc, Prats, Clara, Soriano-Arandes, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937862/
https://www.ncbi.nlm.nih.gov/pubmed/36801975
http://dx.doi.org/10.1007/s00431-023-04862-z
_version_ 1784890518343254016
author Pino, Rosa
Antoñanzas, Jesús M.
Paredes-Carmona, Fernando
Perramon, Aida
Rivière, Jacques G.
Coma, Maria
Martínez-Mejías, Abel
Ripoll, Francesc
López, Núria
Conti, Romina
Sala-Castellví, Pere
Ruiz, Montserrat
Brio, Sonia
García-Lorenzo, Marc
Esteller, Maria
Carreras-Abad, Clara
Herrero-Hernando, Carlos
Schneider, Stephan Otto
Gatell, Anna
Aguilar, Isabel
Cantero, Javier
Ruiz, Gloria
Fenollosa, Teresa
Lobato, Zulema
Villalobos, Pilar
Mora, Emiliano
Anton, Jordi
Visa-Reñé, Núria
Soler-Palacin, Pere
Calavia, Olga
Esquirol-Herrero, Cristina
Guarch-Ibañez, Borja
García-García, Juan-José
Coma, Ermengol
Fina, Francesc
Prats, Clara
Soriano-Arandes, Antoni
author_facet Pino, Rosa
Antoñanzas, Jesús M.
Paredes-Carmona, Fernando
Perramon, Aida
Rivière, Jacques G.
Coma, Maria
Martínez-Mejías, Abel
Ripoll, Francesc
López, Núria
Conti, Romina
Sala-Castellví, Pere
Ruiz, Montserrat
Brio, Sonia
García-Lorenzo, Marc
Esteller, Maria
Carreras-Abad, Clara
Herrero-Hernando, Carlos
Schneider, Stephan Otto
Gatell, Anna
Aguilar, Isabel
Cantero, Javier
Ruiz, Gloria
Fenollosa, Teresa
Lobato, Zulema
Villalobos, Pilar
Mora, Emiliano
Anton, Jordi
Visa-Reñé, Núria
Soler-Palacin, Pere
Calavia, Olga
Esquirol-Herrero, Cristina
Guarch-Ibañez, Borja
García-García, Juan-José
Coma, Ermengol
Fina, Francesc
Prats, Clara
Soriano-Arandes, Antoni
author_sort Pino, Rosa
collection PubMed
description Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe disease temporarily related to SARS-CoV-2. We aimed to describe the epidemiological, clinical, and laboratory findings of all MIS-C cases diagnosed in children < 18 years old in Catalonia (Spain) to study their trend throughout the pandemic. This was a multicenter ambispective observational cohort study (April 2020–April 2022). Data were obtained from the COVID-19 Catalan surveillance system and from all hospitals in Catalonia. We analyzed MIS-C cases regarding SARS-CoV-2 variants for demographics, symptoms, severity, monthly MIS-C incidence, ratio between MIS-C and accumulated COVID-19 cases, and associated rate ratios (RR). Among 555,848 SARS-CoV-2 infections, 152 children were diagnosed with MIS-C. The monthly MIS-C incidence was 4.1 (95% CI: 3.4–4.8) per 1,000,000 people, and 273 (95% CI: 230–316) per 1,000,000 SARS-CoV-2 infections (i.e., one case per 3,700 SARS-CoV-2 infections). During the Omicron period, the MIS-C RR was 8.2 (95% CI: 5.7–11.7) per 1,000,000 SARS-CoV-2 infections, which was significantly lower (p < 0.001) than that for previous variant periods in all age groups. The median [IQR] age of MIS-C was 8 [4–11] years, 62.5% male, and 80.2% without comorbidities. Common symptoms were gastrointestinal findings (88.2%) and fever > 39 °C (81.6%); nearly 40% had an abnormal echocardiography, and 7% had coronary aneurysm. Clinical manifestations and laboratory data were not different throughout the variant periods (p > 0.05).   Conclusion: The RR between MIS-C cases and SARS-CoV-2 infections was significantly lower in the Omicron period for all age groups, including those not vaccinated, suggesting that the variant could be the main factor for this shift in the MISC trend. Regardless of variant type, the patients had similar phenotypes and severity throughout the pandemic. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00431-023-04862-z.
format Online
Article
Text
id pubmed-9937862
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-99378622023-02-21 Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain Pino, Rosa Antoñanzas, Jesús M. Paredes-Carmona, Fernando Perramon, Aida Rivière, Jacques G. Coma, Maria Martínez-Mejías, Abel Ripoll, Francesc López, Núria Conti, Romina Sala-Castellví, Pere Ruiz, Montserrat Brio, Sonia García-Lorenzo, Marc Esteller, Maria Carreras-Abad, Clara Herrero-Hernando, Carlos Schneider, Stephan Otto Gatell, Anna Aguilar, Isabel Cantero, Javier Ruiz, Gloria Fenollosa, Teresa Lobato, Zulema Villalobos, Pilar Mora, Emiliano Anton, Jordi Visa-Reñé, Núria Soler-Palacin, Pere Calavia, Olga Esquirol-Herrero, Cristina Guarch-Ibañez, Borja García-García, Juan-José Coma, Ermengol Fina, Francesc Prats, Clara Soriano-Arandes, Antoni Eur J Pediatr Research Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe disease temporarily related to SARS-CoV-2. We aimed to describe the epidemiological, clinical, and laboratory findings of all MIS-C cases diagnosed in children < 18 years old in Catalonia (Spain) to study their trend throughout the pandemic. This was a multicenter ambispective observational cohort study (April 2020–April 2022). Data were obtained from the COVID-19 Catalan surveillance system and from all hospitals in Catalonia. We analyzed MIS-C cases regarding SARS-CoV-2 variants for demographics, symptoms, severity, monthly MIS-C incidence, ratio between MIS-C and accumulated COVID-19 cases, and associated rate ratios (RR). Among 555,848 SARS-CoV-2 infections, 152 children were diagnosed with MIS-C. The monthly MIS-C incidence was 4.1 (95% CI: 3.4–4.8) per 1,000,000 people, and 273 (95% CI: 230–316) per 1,000,000 SARS-CoV-2 infections (i.e., one case per 3,700 SARS-CoV-2 infections). During the Omicron period, the MIS-C RR was 8.2 (95% CI: 5.7–11.7) per 1,000,000 SARS-CoV-2 infections, which was significantly lower (p < 0.001) than that for previous variant periods in all age groups. The median [IQR] age of MIS-C was 8 [4–11] years, 62.5% male, and 80.2% without comorbidities. Common symptoms were gastrointestinal findings (88.2%) and fever > 39 °C (81.6%); nearly 40% had an abnormal echocardiography, and 7% had coronary aneurysm. Clinical manifestations and laboratory data were not different throughout the variant periods (p > 0.05).   Conclusion: The RR between MIS-C cases and SARS-CoV-2 infections was significantly lower in the Omicron period for all age groups, including those not vaccinated, suggesting that the variant could be the main factor for this shift in the MISC trend. Regardless of variant type, the patients had similar phenotypes and severity throughout the pandemic. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00431-023-04862-z. Springer Berlin Heidelberg 2023-02-18 2023 /pmc/articles/PMC9937862/ /pubmed/36801975 http://dx.doi.org/10.1007/s00431-023-04862-z Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research
Pino, Rosa
Antoñanzas, Jesús M.
Paredes-Carmona, Fernando
Perramon, Aida
Rivière, Jacques G.
Coma, Maria
Martínez-Mejías, Abel
Ripoll, Francesc
López, Núria
Conti, Romina
Sala-Castellví, Pere
Ruiz, Montserrat
Brio, Sonia
García-Lorenzo, Marc
Esteller, Maria
Carreras-Abad, Clara
Herrero-Hernando, Carlos
Schneider, Stephan Otto
Gatell, Anna
Aguilar, Isabel
Cantero, Javier
Ruiz, Gloria
Fenollosa, Teresa
Lobato, Zulema
Villalobos, Pilar
Mora, Emiliano
Anton, Jordi
Visa-Reñé, Núria
Soler-Palacin, Pere
Calavia, Olga
Esquirol-Herrero, Cristina
Guarch-Ibañez, Borja
García-García, Juan-José
Coma, Ermengol
Fina, Francesc
Prats, Clara
Soriano-Arandes, Antoni
Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain
title Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain
title_full Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain
title_fullStr Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain
title_full_unstemmed Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain
title_short Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain
title_sort multisystem inflammatory syndrome in children and sars-cov-2 variants: a two-year ambispective multicentric cohort study in catalonia, spain
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937862/
https://www.ncbi.nlm.nih.gov/pubmed/36801975
http://dx.doi.org/10.1007/s00431-023-04862-z
work_keys_str_mv AT pinorosa multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT antonanzasjesusm multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT paredescarmonafernando multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT perramonaida multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT rivierejacquesg multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT comamaria multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT martinezmejiasabel multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT ripollfrancesc multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT lopeznuria multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT contiromina multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT salacastellvipere multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT ruizmontserrat multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT briosonia multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT garcialorenzomarc multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT estellermaria multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT carrerasabadclara multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT herrerohernandocarlos multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT schneiderstephanotto multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT gatellanna multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT aguilarisabel multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT canterojavier multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT ruizgloria multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT fenollosateresa multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT lobatozulema multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT villalobospilar multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT moraemiliano multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT antonjordi multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT visarenenuria multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT solerpalacinpere multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT calaviaolga multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT esquirolherrerocristina multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT guarchibanezborja multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT garciagarciajuanjose multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT comaermengol multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT finafrancesc multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT pratsclara multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain
AT sorianoarandesantoni multisysteminflammatorysyndromeinchildrenandsarscov2variantsatwoyearambispectivemulticentriccohortstudyincataloniaspain